Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1976 Nov;14(5):1138–1143. doi: 10.1128/iai.14.5.1138-1143.1976

T-lymphocyte number and function and the course of hepatitis B in hemodialysis patients.

G C De Gast, B Houwen, G K van der Hem, T H The
PMCID: PMC415505  PMID: 1086288

Abstract

To study the relation between general cellular immunity and the course of hepatitis B within a group of chronic hemodialysis patients, T-lymphocyte number and function were investigated in 13 persistently hepatitis B surface antigen (HBSAg)-positive patients, in 32 HBSAg-negative patients, and in 11 patients who had recovered from hepatitis B and compared with that of 21 age-matched controls. Phytohemagglutinin-induced lymphocyte stimulation in vitro and the number of circulating T-cells in the HBSAg-positive group were significantly decreased as compared with those of the recovered group and the controls. Lymphocyte stimulation by pokeweed mitogen and by an antigen cocktail showed the same tendency, but no significant differences between the HBSAg-positive and the recovered groups. Uremic sera from the three patient groups had similar depressive effects on phytohemagglutinin induced lymphocyte stimulation of controls. Serum immunoglobulin G, (IgG), IgA, and IgM were normal in the three patient groups. It is concluded that chronic hemodialysis patients, who have become persistent HBSAg-carriers, have a significantly decreased T-lymphocyte number and function as compared with hemodialysis patients who are able to eliminat hepatitis B virus (HBV). The difference could not be ascribed to the HBV infection itself. This indicates that T-cells play an important role in the elimination of HBV in hemodialysis patients.

Full text

PDF
1138

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agarwal S. S., Blumberg B. S., Gerstley B. J., London W. T., Millman I., Sutnick A. I., Loeb L. A. Lymphocyte transformation and hepatitis. I. Impairment of thymidine incorporation and DNA polymerase activity. Proc Soc Exp Biol Med. 1971 Sep;137(4):1498–1502. doi: 10.3181/00379727-137-35818. [DOI] [PubMed] [Google Scholar]
  2. Bolin T. D., Davis A. E., Liddelow A. G. Liver disease and cell-mediated immunity in hepatitis-associated antigen (HAA) carriers. Gut. 1973 May;14(5):365–368. doi: 10.1136/gut.14.5.365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chen T. S., Leevy C. M. Liver regeneration and uraemia. Br J Exp Pathol. 1973 Dec;54(6):591–596. [PMC free article] [PubMed] [Google Scholar]
  4. DAMMIN G. J., COUCH N. P., MURRAY J. E. Prolonged survival of skin homografts in uremic patients. Ann N Y Acad Sci. 1957 Mar 22;64(5):967–976. doi: 10.1111/j.1749-6632.1957.tb52488.x. [DOI] [PubMed] [Google Scholar]
  5. Dudley F. J., Fox R. A., Sherlock S. Cellular immunity and hepatitis-associated, Australia antigen liver disease. Lancet. 1972 Apr 1;1(7753):723–726. doi: 10.1016/s0140-6736(72)90234-6. [DOI] [PubMed] [Google Scholar]
  6. Geha R. S., Merler E. Response of human thymus-derived (T) and non-thymus-derived (B) lymphocytes to mitogenic stimulation in vitro. Eur J Immunol. 1974 Mar;4(3):193–199. doi: 10.1002/eji.1830040308. [DOI] [PubMed] [Google Scholar]
  7. Giustino V., Dudley F. J., Sherlock S. Thymus-dependent lymphocyte function in patients with hepatitis-associated antigen. Lancet. 1972 Oct 21;2(7782):850–853. doi: 10.1016/s0140-6736(72)92212-x. [DOI] [PubMed] [Google Scholar]
  8. Jondal M., Holm G., Wigzell H. Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J Exp Med. 1972 Aug 1;136(2):207–215. doi: 10.1084/jem.136.2.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Laiwah A. A. Lymphocyte transformation by Australia antigen. Lancet. 1971 Aug 28;2(7722):470–471. doi: 10.1016/s0140-6736(71)92633-x. [DOI] [PubMed] [Google Scholar]
  10. London W. T., Di Figlia M., Sutnick A., Blumberg B. S. An epidemic of hepatitis in a chronic-hemodialysis unit. Australia antigen and differences in host response. N Engl J Med. 1969 Sep 11;281(11):571–578. doi: 10.1056/NEJM196909112811101. [DOI] [PubMed] [Google Scholar]
  11. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  12. Matchett K. M., Huang A. T., Kremer W. B. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes. J Clin Invest. 1973 Aug;52(8):1908–1917. doi: 10.1172/JCI107374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Millman I., Agarwal S. S., Bugbee S. J., Blumberg B. S., Loeb L. A. Lymphocyte transformation and hepatitis. II. Lack of direct in vitro inhibition by purified Australia antigen. Proc Soc Exp Biol Med. 1971 Oct;138(1):198–203. doi: 10.3181/00379727-138-35861. [DOI] [PubMed] [Google Scholar]
  14. Newberry W. M., Sanford J. P. Defective cellular immunity in renal failure: depression of reactivity of lymphocytes to phytohemagglutinin by renal failure serum. J Clin Invest. 1971 Jun;50(6):1262–1271. doi: 10.1172/JCI106604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Nielsen J. O., Reinicke V., Dietrichson O., Andersen V., Thomsen M., Andersen E. Immunological studies of Australia antigen carriers with and without liver diseases. Clin Exp Immunol. 1973 Sep;15(1):9–16. [PMC free article] [PubMed] [Google Scholar]
  16. Notkins A. L., Mergenhagen S. E., Howard R. J. Effect of virus infections on the function of the immune system. Annu Rev Microbiol. 1970;24:525–538. doi: 10.1146/annurev.mi.24.100170.002521. [DOI] [PubMed] [Google Scholar]
  17. Rashid A., Sengar D., McLeish W., Sutherland M., Harris J., Couture R. The effect of host immunity on hepatitis B antigen (HBAg) infection in hemodialysis patiets. Trans Am Soc Artif Intern Organs. 1975;21:483–487. [PubMed] [Google Scholar]
  18. Selroos O., Pasternack A., Virolainen M. Skin test sensitivity and antigen-induced lymphocyte transformation in uraemia. Clin Exp Immunol. 1973 Jul;14(3):365–370. [PMC free article] [PubMed] [Google Scholar]
  19. Sutnick A. I., Bugbee S. J., London W. T., Loeb L. A., Peyretti F., Litwin S., Blumberg B. S. Lymphocyte function in normal people with persistent Australia antigen. J Lab Clin Med. 1973 Jul;82(1):79–85. [PubMed] [Google Scholar]
  20. Tong M. J., Wallace A. M., Peters R. L., Reynolds T. B. Lymphocyte stimulation in hepatitis B infections. N Engl J Med. 1975 Aug 14;293(7):318–322. doi: 10.1056/NEJM197508142930702. [DOI] [PubMed] [Google Scholar]
  21. Touraine J. L., Touraine F., Revillard J. P., Brochier J., Traeger J. T-lymphocytes and serum inhibitors of cell-mediated immunity in renal insufficiency. Nephron. 1975;14(2):195–208. doi: 10.1159/000180448. [DOI] [PubMed] [Google Scholar]
  22. de Gast G. C., Houwen B., Nieweg H. O. Specific lymphocyte stimulation by purified, heat-inactivated hepatitis-B antigen. Br Med J. 1973 Dec 22;4(5894):707–709. doi: 10.1136/bmj.4.5894.707. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES